PCI Pharma Services
About Company
“Accelerating life-changing therapies from development to delivery.”
PCI Pharma Services is a global CDMO (Contract Development and Manufacturing Organization) providing integrated pharmaceutical services from drug development to commercial launch and beyond. With 4300 employees in 30 global GMP facilities, the company offers services such as drug development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging. PCI Pharma Services is committed to Environmental Social Governance (ESG) and offers real-time supply chain information through its pci | bridge™ platform. The company’s Speed Solutions aim to accelerate drug products from development to commercialization. With a focus on driving development and connecting commercialization, PCI Pharma Services provides comprehensive pharmaceutical services and operates globally with facilities in North America, Europe, and Asia Pacific.
